CoChat

The Association Between Medication Adherence and Health-Related Quality of Life in Patients with COPD: A Cross-Sectional Study

Open access
Saja, Maha, Younis, Afnan, Alzahrani, Lamiss, Alkhlassi, Ibtisam, Aldakhil, Lama, Albayyat, Rawan, Alnasser, Noura, Alokla, Khalid, Alghamdi, Lamia, Rashed, Albatol, Azer, Samy · 2025 · International Journal of Chronic Obstructive Pulmonary Disease

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Abstract

Purpose: Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition with debilitating manifestations that adversely affect patients' health-related quality of life (HRQoL). The clinical course is complicated by patients' low medication adherence level. Low adherence and poor HRQoL are linked to unfavorable disease outcomes. Although many factors affect adherence and HRQoL in COPD, the impact of adherence on HRQoL remain controversial. This study aimed to measure medication adherence and its impact on HRQoL in patients with COPD. Patients and Methods: This cross-sectional observational study included patients with COPD from two health centers in Riyadh, Saudi Arabia. Patients were identified using the medical database and only those fulfilling the GOLD 2020 criteria for COPD diagnosis were recruited. Data were collected via phone interviews and included sociodemographic information, the level of medication adherence assessed using the 5-item Medication Adherence Report Scale (MARS-5), and the HRQoL measured using the St. George Respiratory Questionnaire for COPD (SGRQ-C). Simple and multiple-regression analysis was used to study the factors affecting both parameters and the relation between adherence and HRQoL. Results: The mean MARS-5 score was 21.17± 4.8 (mean ± SD) with only 56.4% of patients with COPD reporting high adherence to their medications. The average total SGRQ score was 51.35 ± 23.82 indicating low HRQoL. Using multiple-regression analysis, comorbidity and intermediate disease duration were associated with lower adherence, while older age, female gender, polypharmacy, and concomitant hypertension predicted lower HRQoL. Moreover, higher adherence to medications was associated with higher overall HRQoL in patients with COPD. Conclusion: Patients with COPD have low medication adherence and low HRQoL. Several patient-, disease-, and therapy-related factors were shown to affect both outcomes; however, higher adherence to medication per se was associated with higher HRQoL in patients with COPD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/copd.s509949

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical abstract
Graphical abstract CC BY-NC · PubMed Central
Figure 1 Multivariable analysis of predictors of medication adherence in patients with COPD receiving regular medications. The analysis was done using multiple linear regression and was conducted on the group of patients receiving regular medications (n=376). The regression model explained 9.4% of the variation seen in the level of medication adherence in patients with COPD, R2adjusted= 0.094, F (12, 363) = 4.254, p-value = <0.001. A p-value of < 0.05 was considered significant. Higher MARS-5 scores indicated higher adherence.
Figure 1 Multivariable analysis of predictors of medication adherence in patients with COPD receiving regular medications. The analysis was done using multiple linear regression and was conducted on the group of patients receiving regular medications (n=376). The regression model explained 9.4% of the variation seen in the level of medication adherence in patients with COPD, R2adjusted= 0.094, F (12, 363) = 4.254, p-value = <0.001. A p-value of < 0.05 was considered significant. Higher MARS-5 scores indicated higher adherence.CC BY-NC · PubMed Central
Figure 2 Multivariable analysis of predictors of HRQoL in patients with COPD receiving regular medications. Multiple linear regression was used to predict the HRQoL (outcome variable) in patients with COPD receiving regular medications given the above predictors. The model included Mars-5 total score as one of the predictors and as such it was analyzed on the group of patients on regular medications (n=376). The regression model explained 36% of the variation seen in total SGRQ scores in patients with COPD, R2adjusted = 0.360, F (16, 359) = 14.186, p-value = <0.001. A p-value of < 0.05 was considered significant. Higher SGRQ scores indicate lower HRQoL.
Figure 2 Multivariable analysis of predictors of HRQoL in patients with COPD receiving regular medications. Multiple linear regression was used to predict the HRQoL (outcome variable) in patients with COPD receiving regular medications given the above predictors. The model included Mars-5 total score as one of the predictors and as such it was analyzed on the group of patients on regular medications (n=376). The regression model explained 36% of the variation seen in total SGRQ scores in patients with COPD, R2adjusted = 0.360, F (16, 359) = 14.186, p-value = <0.001. A p-value of < 0.05 was considered significant. Higher SGRQ scores indicate lower HRQoL.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 78 references

Research works printed but not linked: 4

  1. Almutairi, 2015, Iran J Public Health, 44, 170
  2. Tóthová, 2014, Neuro Endocrinol Lett, 35, 11
  3. 2016, George’s Respiratory Questionnaire for COPD Patients (SGRQ-C) Manual
  4. Xu, 2009, Int J Tuberc Lung Dis, 13, 181

Cited by

See all 10

Metadata

Authors
Saja, M., Younis, A., Alzahrani, L., Alkhlassi, I., Aldakhil, L., Albayyat, R., Alnasser, N., Alokla, K., Alghamdi, L., Rashed, A., & Azer, S.
Affiliations
  • King Saud University (SA)
  • King Fahd Medical City (SA)
Corresponding author
Saja, Maha
Venue
International Journal of Chronic Obstructive Pulmonary Disease
Published
2025-05
Volume
Volume 20
Pages
1567-1583
ISSN
  • 1176-9106 (ISSN-L)
  • 1178-2005
OpenAlex
W4410517144
Cited by
10
References
78
Citations by year
2026: 9 · 2025: 1
FWCI
13.33
Type
journal article
Language
en
Open access
Locations
  • International Journal of COPD (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
chronic obstructive pulmonary disease, medication adherence, health-related quality of life, MARS-5, St George's Respiratory Questionnaire, comorbidities, disease duration, polypharmacy, hypertension, sociodemographic factors
MeSH terms
Aged, Bronchodilator Agents, Cross-Sectional Studies, Female, Humans, Lung, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Risk Factors, Saudi Arabia, Treatment Outcome, Polypharmacy, Pulmonary Disease, Chronic Obstructive, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.